Author

Julia Schaefer-Cutillo

Observed name: Julia Schaefer-cutillo

Institutions: Northwell Health, Northern Westchester Hospital

Observed institutions: Northwell Health, University of Rochester Medicine, Yale University, Northern Westchester Hospital, University of Rochester

OpenAlex ID: A5017430403

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

2009 · Jonathan W. Friedberg, Jeff Sharman, et al. · Blood · 747

Fostamatinib Disodium (FosD), An Oral Inhibitor of Syk, Is Well-Tolerated and Has Significant Clinical Activity in Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukemia (SLL/CLL)

2008 · Jonathan W. Friedberg, Jeff Sharman, et al. · Blood · 29

Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders

2020 · David J. Araten, H. Michael Belmont, et al. · American Journal of Case Reports · 21

Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion

2012 · Paul M. Barr, Chungwen Wei, et al. · Clinical Immunology · 21

Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma.

2007 · Julia Schaefer-Cutillo, Jonathan W Friedberg, et al. · PubMed · 19

Non-myeloablative Radioimmunotherapy for Non-Hodgkin’s Lymphoma

2008 · Julia Schaefer-Cutillo, Jonathan W. Friedberg · Seminars in Hematology · 5

Effect of Prior Rituximab on Residence Time of I131 Tositumomab Consolidation Therapy in Patients (pts) with Non Hodgkin’s Lymphoma (NHL): Analysis of SWOG Clinical Trials.

2008 · Julia Schaefer-Cutillo, Vaseem Chengazi, et al. · Blood

Knock-Down of CCAAT Displacement Protein (CDP) Restores Specific Granule Protein (SGP) Gene Expression in NB4 Acute Promyelocytic Leukemia Cells.

2005 · Jacqueline M. Tromp, Aimee L. Lucas, et al. · Blood

Works count: 9

Citation count: 842

H-index: 5

I10-index: 5